FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices

Source :: Financial Law Reporter. September 21, 2024
Publication Year :: 2024
Abstract: Washington, D.C.: US Federal Trade Commission has issued the following news release: Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)--Caremark Rx, Express [...]

Subjects :: United States. Federal Trade Commission
CVS Health Corp. -- Prices and rates
CIGNA Corp. -- Prices and rates
Caremark Rx Inc. -- Prices and rates
Express Scripts Inc. -- Prices and rates
UnitedHealth Group Inc. -- Prices and rates
Health maintenance organizations -- Prices and rates
Diabetes therapy -- Prices and rates
Restraint of trade
Drugs -- Prescribing
Drugstores -- Prices and rates
Group purchasing organizations
Insulin -- Prices and rates
Company pricing policy
News, opinion and commentary

Tools